[go: up one dir, main page]

DE69732881D1 - Verwendung von zusammensetzungen mit stabilisierten enzymen - Google Patents

Verwendung von zusammensetzungen mit stabilisierten enzymen

Info

Publication number
DE69732881D1
DE69732881D1 DE69732881T DE69732881T DE69732881D1 DE 69732881 D1 DE69732881 D1 DE 69732881D1 DE 69732881 T DE69732881 T DE 69732881T DE 69732881 T DE69732881 T DE 69732881T DE 69732881 D1 DE69732881 D1 DE 69732881D1
Authority
DE
Germany
Prior art keywords
compositions
stabilized enzymes
enzymes
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732881T
Other languages
English (en)
Other versions
DE69732881T2 (de
Inventor
Luppo Edens
Sheng Tan
Wilhelmus Lambers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Goldschmidt GmbH
Original Assignee
Cosmoferm BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27443289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69732881(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmoferm BV filed Critical Cosmoferm BV
Publication of DE69732881D1 publication Critical patent/DE69732881D1/de
Application granted granted Critical
Publication of DE69732881T2 publication Critical patent/DE69732881T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
    • B05B11/1081—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping
    • B05B11/1084—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping each liquid or other fluent material being pumped by a separate pump

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69732881T 1996-01-31 1997-01-31 Verwendung von zusammensetzungen mit stabilisierten enzymen Expired - Lifetime DE69732881T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP96200190 1996-01-31
EP96200190 1996-01-31
EP96200594 1996-03-08
EP96200594 1996-03-08
EP96201713 1996-06-21
EP96201713 1996-06-21
EP96202781 1996-10-03
EP96202781 1996-10-03
PCT/EP1997/000507 WO1997027841A1 (en) 1996-01-31 1997-01-31 Use of compositions comprising stabilized biologically effective compounds

Publications (2)

Publication Number Publication Date
DE69732881D1 true DE69732881D1 (de) 2005-05-04
DE69732881T2 DE69732881T2 (de) 2006-04-06

Family

ID=27443289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732881T Expired - Lifetime DE69732881T2 (de) 1996-01-31 1997-01-31 Verwendung von zusammensetzungen mit stabilisierten enzymen

Country Status (16)

Country Link
US (1) US6117433A (de)
EP (1) EP0817613B1 (de)
JP (1) JPH11503465A (de)
KR (1) KR100517060B1 (de)
CN (1) CN1140261C (de)
AR (1) AR006308A1 (de)
AT (1) ATE291897T1 (de)
AU (1) AU1721697A (de)
BR (1) BR9702049B1 (de)
CA (1) CA2216169C (de)
DE (1) DE69732881T2 (de)
ES (1) ES2237789T3 (de)
ID (1) ID18666A (de)
MX (1) MX9707487A (de)
PT (1) PT817613E (de)
WO (1) WO1997027841A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5947335A (en) * 1996-10-15 1999-09-07 Lever Brothers Company Dual compartment package
US6082588A (en) * 1997-01-10 2000-07-04 Lever Brothers Company, Division Of Conopco, Inc. Dual compartment package and pumps
BR9810985A (pt) 1997-07-08 2000-08-15 Dsm Nv Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
KR100351620B1 (ko) * 1999-07-09 2002-09-10 주식회사대성미생물연구소 3차 결정구조의 내열성 효소
KR100340086B1 (ko) * 1999-08-27 2002-06-12 안용찬 비듬방지용 샴푸조성물
US6585984B1 (en) * 2000-03-03 2003-07-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
AU2001255487A1 (en) * 2000-04-21 2001-11-07 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
MXPA03002169A (es) * 2000-09-13 2003-07-24 Procter & Gamble Composiciones cosmeticas.
MXPA03002168A (es) * 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico.
US20030206897A1 (en) * 2000-09-13 2003-11-06 The Procter & Gamble Company Cosmetic compositions
MXPA03002167A (es) * 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico.
AU2000274827A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic compositions
AU2000274801A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic method for treatment of skin and/or hair
JP2002326924A (ja) * 2001-05-07 2002-11-15 Hayashibara Biochem Lab Inc 洗顔料
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
ATE423104T1 (de) * 2001-11-03 2009-03-15 Astrazeneca Ab Quinazolin derivate als antitumor-mittel
US20080152722A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Skin care composition
US20080152613A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Method for manufacturing a skin care composition
CA2416305A1 (en) * 2002-01-31 2003-07-31 Davies, John Shaving, after-shave, and skin conditioning compositions
TW200813014A (en) * 2002-03-28 2008-03-16 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) * 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
FR2840215B1 (fr) * 2002-06-03 2004-08-27 Oreal Composition contenant un actif susceptible d'etre oxyde par un hydroperoxyde, une lipoxygenase et un substrat et procede mettant en oeuvre cette composition
DE10241073A1 (de) * 2002-09-05 2004-03-11 Beiersdorf Ag Kosmetikum mit aktivierbaren Pflegekomponenten
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
DE602004023796D1 (de) * 2003-08-20 2009-12-10 Seikagaku Kogyo Co Ltd Stabilisierungsmittel für Enzyme
DE10342211A1 (de) * 2003-09-12 2005-04-07 Beiersdorf Ag Kosmetikum
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
EP1664028A1 (de) * 2003-09-16 2006-06-07 AstraZeneca AB Chinazolinderivate als tyrosinkinaseinhibitoren
PL1667992T3 (pl) * 2003-09-19 2007-05-31 Astrazeneca Ab Pochodne chinazoliny
ATE353888T1 (de) * 2003-09-19 2007-03-15 Astrazeneca Ab Chinazolinderivate
US20070043010A1 (en) * 2003-09-25 2007-02-22 Astrazeneca Uk Limited Quinazoline derivatives
ATE548127T1 (de) * 2003-10-03 2012-03-15 Kao Corp Abführvorrichtung
ATE429897T1 (de) * 2003-10-10 2009-05-15 Cosmedical Aps Haarwuchshemmung
MXPA06004827A (es) * 2003-10-31 2006-07-03 Procter & Gamble Metodo para proveer una composicion combinada.
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
CA2567832A1 (en) * 2004-06-04 2005-12-15 Astrazeneca Ab Quinazoline derivatives as erbb receptor tyrosine kinases
JP2005350384A (ja) * 2004-06-09 2005-12-22 Blc:Kk 基礎化粧方法
WO2006020208A2 (en) 2004-07-26 2006-02-23 Merz Pharma Gmbh & Co. Kgaa Therapeutic composition whit a botulinum neurotoxin
DE602005026865D1 (de) 2004-12-14 2011-04-21 Astrazeneca Ab Pyrazolopyrimidinverbindungen als antitumormittel
UY29398A1 (es) * 2005-02-26 2006-10-02 Astrazeneca Ab Derivados de quinazolinas, sussales farmacéuticamente aceptables, composiciones que los contienen, procedimientos de preparación y aplicacións.
GB0504474D0 (en) * 2005-03-04 2005-04-13 Astrazeneca Ab Chemical compounds
GB0508715D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
GB0508717D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
US7378084B2 (en) * 2005-07-01 2008-05-27 Playtex Products, Inc. Sunless tanning composition and method of sunless tanning
JP2009505693A (ja) * 2005-08-10 2009-02-12 マヤバイオテック・リミテッド 局所投与のための薬剤送達システム
EP1928861B1 (de) * 2005-09-20 2010-11-17 AstraZeneca AB 4-(1h-indazol-5-ylamino)chinazolinverbindungen als inhibitoren der erbb-rezeptortyrosinkinase zur behandlung von krebs
US20090239861A1 (en) * 2005-09-20 2009-09-24 Robert Hugh Bradbury Quinazoline derivatives as anticancer agents
USD543865S1 (en) 2005-09-20 2007-06-05 Walters Peter J Dual dispenser package with dual actuators
USD543864S1 (en) 2005-09-20 2007-06-05 Cho Sean H Dual dispenser package with single actuator
DE602006009304D1 (de) * 2005-12-02 2009-10-29 Astrazeneca Ab Chinazoleinderivate
WO2007063291A1 (en) * 2005-12-02 2007-06-07 Astrazeneca Ab 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
EP1921070A1 (de) * 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
US7998949B2 (en) * 2007-02-06 2011-08-16 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
US8569221B2 (en) * 2007-08-30 2013-10-29 Kimberly-Clark Worldwide, Inc. Stain-discharging and removing system
CA2711582A1 (en) 2008-02-07 2009-08-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
CA2723989C (en) 2008-05-13 2017-04-25 Astrazeneca Ab Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline
US8648191B2 (en) * 2008-08-08 2014-02-11 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20120076766A1 (en) * 2010-04-21 2012-03-29 Phillips D Howard Topical drug delivery system with dual carriers
EP2886163A1 (de) 2011-12-20 2015-06-24 Oriflame Research and Development Ltd. Verbindungen mit Anti-Aging-Wirkung
US9931657B2 (en) * 2014-04-18 2018-04-03 The Clorox Company Dual chamber spray dispenser with a single delivery tube
CN107177582B (zh) * 2016-02-16 2018-05-22 上海青瑞食品科技有限公司 一种液体酶制剂及制备方法
EP3231420A1 (de) 2016-02-29 2017-10-18 G.L. Pharma GmbH Missbrauchsverhindernde pharmazeutische zusammensetzungen
EP3210596A1 (de) 2016-02-29 2017-08-30 G.L. Pharma GmbH Missbrauchsverhindernde pharmazeutische zusammensetzung
EP3210630A1 (de) 2016-02-29 2017-08-30 G.L. Pharma GmbH Missbrauch-abschreckende pharmazeutische zusammensetzungen
FR3052035B1 (fr) 2016-06-02 2020-10-09 Oreal Systeme de distribution d'un produit cosmetique
ES2832555T3 (es) 2017-03-27 2021-06-10 Evonik Operations Gmbh Procedimiento y producto para la preparación de formulaciones con contenido en ceramida
WO2018182252A1 (ko) * 2017-03-31 2018-10-04 주식회사 아모레퍼시픽 아멘토플라본의 안정도가 향상된 투명 또는 반투명 화장료 조성물
WO2018195415A1 (en) * 2017-04-21 2018-10-25 Phi Therapeutics, Inc. Compositions comprising propionibacterium acnes bacteriophages for treating acne
IT201900006994A1 (it) * 2019-05-20 2020-11-20 Biodermol Ambiente S R L Ceppi batterici per uso industriale
AU2020387478A1 (en) * 2019-11-22 2022-06-16 Samyang Holdings Corporation Kit for preparing nanoparticle composition for drug delivery
KR20230029260A (ko) * 2021-08-24 2023-03-03 (주)아모레퍼시픽 효소 손상을 방지하는 화장료 조성물 및 이를 저장하는 화장품 용기

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6318M (de) * 1967-04-04 1968-09-23
FR2032202A5 (de) * 1969-02-21 1970-11-20 Oreal
US3834075A (en) * 1973-02-12 1974-09-10 Tre X Injector Syst Co Tree trunk pressure feeding device
US3992813A (en) * 1975-07-07 1976-11-23 Freshel David C Tree treating system
US4243543A (en) * 1979-05-11 1981-01-06 Economics Laboratory, Inc. Stabilized liquid enzyme-containing detergent compositions
US4556554A (en) * 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
AU3667189A (en) * 1988-06-23 1990-01-04 Unilever Plc Enzyme-containing liquid detergents
US4959179A (en) * 1989-01-30 1990-09-25 Lever Brothers Company Stabilized enzymes liquid detergent composition containing lipase and protease
WO1991000094A1 (en) * 1989-06-28 1991-01-10 Finn Tranberg A new papaverine injection system
JPH05502584A (ja) * 1989-12-21 1993-05-13 ノボ　ノルディスク　アクティーゼルスカブ 酵素含有調製品及び該調製品を含有する洗剤
DE4023601A1 (de) * 1990-07-25 1992-01-30 Henkel Kgaa Fluessige enzymzubereitung
DE4121820A1 (de) * 1991-07-02 1993-01-07 Basf Ag Mikrokapseldispersionen
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5252312A (en) * 1992-09-30 1993-10-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Package effervescible composition
JP2866741B2 (ja) * 1993-03-31 1999-03-08 シェリング−プラウ・ヘルスケア・プロダクツ・インコーポレーテッド 日光なし日焼けのための方法と装置
CN1064074C (zh) * 1993-12-03 2001-04-04 巴科曼实验室国际公司 用嵌段共聚物促使酶稳定
US5843409A (en) * 1994-08-08 1998-12-01 Colgate Palmolive Company Two component dentifrice for the treatment of dentinal hypersensitivity
FR2725897B1 (fr) * 1994-10-24 1996-12-06 Oreal Produit pour application topique contenant une lipase et un precurseur d'actif

Also Published As

Publication number Publication date
CN1178460A (zh) 1998-04-08
AU1721697A (en) 1997-08-22
EP0817613B1 (de) 2005-03-30
BR9702049A (pt) 1998-01-13
MX9707487A (es) 1997-11-29
DE69732881T2 (de) 2006-04-06
WO1997027841A1 (en) 1997-08-07
CN1140261C (zh) 2004-03-03
ES2237789T3 (es) 2005-08-01
AR006308A1 (es) 1999-08-25
US6117433A (en) 2000-09-12
PT817613E (pt) 2005-06-30
KR100517060B1 (ko) 2006-05-25
ATE291897T1 (de) 2005-04-15
KR19980703467A (ko) 1998-11-05
BR9702049B1 (pt) 2010-08-10
ID18666A (id) 1998-04-30
JPH11503465A (ja) 1999-03-26
CA2216169C (en) 2007-01-23
EP0817613A1 (de) 1998-01-14
CA2216169A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
DE69732881D1 (de) Verwendung von zusammensetzungen mit stabilisierten enzymen
DE69739892D1 (de) Verwendung von perlförmigen Nahrungsmittelzusätzen
ATE261763T1 (de) Verwendung von einer verkapselten bioaktiven zusammensetzung
DE69831589D1 (de) Zusammenfügung von knorpelmatrizen unter verwendung isolierter chondrozyten
ATE423192T1 (de) Mutanten der alpha-amylase
DE69732684D1 (de) Automatische Modifizierung von Dokumentgestaltungen
DE69635904D1 (de) Sauerstoffentfernende zusammensetzungen mit geringer wanderung
DE69414543D1 (de) Verwendung von Zusammensetzungen zur Schaumregulierung
DE69708028D1 (de) 1,2-Bis-Addukte von Introxyden mit substituierten Äthylenen und stabilisierte Zusammensetzungen
DE69522579D1 (de) Verwendung von spezifische lipolytische enzyme in reinigungsmitteln
ATE186447T1 (de) Zusammensetzung und verwendung
DE59804446D1 (de) Kosmetische zusammensetzungen mit agglomerierten substraten
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DE69732435D1 (de) Verwendung von 1-nonen-3-one als aromastoff
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69806419D1 (de) Harzzusammensetzung und ihre Verwendung
DE69804513D1 (de) Herstellung von zeolith-l
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
DE69737853D1 (de) Herstellung von L(+)-Lactat
DE69822509D1 (de) Zusammensetzung von alditol-acetalen und ihrer verwendung
DE59701610D1 (de) Verwendung von sarkosinaten als asphalten-dispergatoren
ID16838A (id) Komposisi dekafluoropentana
DE69623493D1 (de) Enzymatische zusammensetzung
ATE230983T1 (de) Neue verwendung von kreatin
DE69711223D1 (de) Verwendung von cordia dichotoma extrakten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 817613

Country of ref document: EP

Owner name: EVONIK GOLDSCHMIDT GMBH, DE

Free format text: FORMER OWNER: COSMOFERM B.V., DELFT, NL

Effective date: 20121115